Find the Perfect Plan for Your Investment Journey
S
Last Price
52 Week Range
CA$0.15 - CA$0.43
Next Earnings Date
Jun 12 2025 (Estimate)
Next Earnings Date
Jun 12 2025 (Est.)
Last Price
Market Cap | CA$65.70M |
EV | CA$65.04M |
Shares Outstanding | 328.48M |
Beta | 1.21 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CA$2.50 |
P/E 2025E | - |
P/Revenue 2025E | 6.73x |
Revenue | - |
EPS | -49.40% |
Operating Cash Flow | -40.30% |
Free Cash Flow | -38.80% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 0.00% |
Net Profit Margin 2025E | - |
ROE 2025E | -925.00% |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
S
Sernova Corp.
SVA
Sector
Healthcare
Industry
Biotechnology
CEO
Data Unavailable
Employees
17
Website
www.sernova.comIPO Date
1999-04-29
Headquarters
The Stiller Centre, Suite 114, 700 Collip Circle, London, Ontario, N6G 4X8, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved